Naomi G. Dempsey

Oncology
8900 N Kendall Dr
Miami, FL 33176

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC).

Multicenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2-low metastatic breast cancer (MBC).

Journal: NPJ breast cancer
Published: November 16, 2024

Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

Journal: Clinical lung cancer
Published: August 22, 2023

Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?

Metastatic HER2-Positive Breast Cancer: Is There an Optimal Sequence of Therapy?

Journal: Current treatment options in oncology
Published: May 13, 2023

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 19, 2022

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.

Journal: European journal of cancer (Oxford, England : 1990)
Published: January 13, 2022

Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies.

Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies.

Journal: Breast cancer research and treatment
Published: March 16, 2021

Systemic Amyloidosis Caused by Monoclonal Immunoglobulins: Soft Tissue and Vascular Involvement.

Systemic Amyloidosis Caused by Monoclonal Immunoglobulins: Soft Tissue and Vascular Involvement.

Journal: Hematology/oncology clinics of North America
Published: October 25, 2020

Resource-Stratified Guideline-Based Cancer Care Should Be a Priority: Historical Context and Examples of Success.

Resource-Stratified Guideline-Based Cancer Care Should Be a Priority: Historical Context and Examples of Success.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 01, 2020

Thyroid Storm Triggered by Strangulation in a Patient with Undiagnosed Graves' Disease.

Thyroid Storm Triggered by Strangulation in a Patient with Undiagnosed Graves' Disease.

Journal: Case reports in endocrinology
Published: November 08, 2017

Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.

Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: February 01, 2015
Showing 1-10 of 10

Last Updated: 09/26/2026